AI-assisted Colonoscopy Report System In Improving Reporting Quality
Speech and Image Recognition Based System in Improving Reporting Quality During Colonoscopy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Honggang Yu, MD
- Phone Number: 13871281899
- Email: yuhonggang1969@163.com
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430060
- Renmin Hospital of Wuhan Univercity
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients:
- Male or female ≥18 years old;
- Able to read, understand and sign an informed consent;
- The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures;
- Patients requiring colonoscopy.
Doctors:
- Males or females who are over 18 years old;
- After qualified medical education and obtaining the Physician's Practice License.
Exclusion Criteria:
Patients:
- Have drug or alcohol abuse or mental disorder in the last 5 years;
- Pregnant or lactating women;
- Patients with known multiple polyp syndrome;
- patients with known inflammatory bowel disease;
- known intestinal stenosis or space-occupying tumor;
- known colon obstruction or perforation;
- patients with a history of colorectal surgery;
- Patients with a previous history of allergy to pre-used spasmolysis;
- Unable to perform biopsy due to coagulation disorders or oral anticoagulants;
- High-risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial.
Doctors:
1. The researcher believes that the subjects are not suitable for participating in clinical trials.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: with Artificial intelligence assistant system
Endoscopists would complete the colonoscopy report with the assistance of the artificial intelligence system.
|
The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions based on speech recognition and deep learning.
|
|
No Intervention: without Artificial intelligence assistant system
Endoscopists would complete the colonoscopy report without special prompts.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The integrity of colonoscopy report
Time Frame: One month
|
Report integrity with or without AI-assisted.
Calculation method = number of information recorded / total number of information need to record x 100%
|
One month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The integrity of capturing anatomical landmarks
Time Frame: One month
|
The integrity in captured bowel landmrak images with or without AI-assisted.
Calculation method = number of anatomical landmarks in captured images / total number of anatomical landmarks x 100%
|
One month
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The integrity of report lesion
Time Frame: One month
|
Report lesion integrity with or without AI-assisted.
Calculation method = number of report lesions / total number of lesions x 100%
|
One month
|
|
The completeness of structured description
Time Frame: One month
|
The completeness of structured description with or without AI-assisted.
Calculation method = number of structured descriptions / total number of structured descriptions need to record x 100%
|
One month
|
|
Accuracy of lesion reporting
Time Frame: One month
|
Accuracy of lesion report with or without AI-assisted.
Calculation method = number of lesions with correct description / total number of lesions descriptionx 100%
|
One month
|
|
The time for reporting
Time Frame: One month
|
The time for reporting with or without AI-assisted
|
One month
|
|
The satisfaction with the reporting system
Time Frame: One month
|
The satisfaction with the reporting system with or without AI-assisted
|
One month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- EA-23-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.